N-(3-Cyano-4,5,6,7-tetrahydrobenzo[b]thienyl-2-yl)-1-naphthalenecarboxamide
2物価
選択條件:
ブランド
- 富士フイルム和光純薬株式會社(wako)
パッケージ
- 10mg
- 50mg
- 生産者富士フイルム和光純薬株式會社(wako)
- 製品番號W01TOC2827
- 製品説明
- 英語製品説明TCS JNK 5a
- 包裝単位10mg
- 価格¥64000
- 更新しました2024-03-01
- 購入
- 生産者富士フイルム和光純薬株式會社(wako)
- 製品番號W01TOC2827
- 製品説明
- 英語製品説明TCS JNK 5a
- 包裝単位50mg
- 価格¥270000
- 更新しました2024-03-01
- 購入
生産者 | 製品番號 | 製品説明 | 包裝単位 | 価格 | 更新時(shí)間 | 購入 |
---|---|---|---|---|---|---|
富士フイルム和光純薬株式會社(wako) | W01TOC2827 | TCS JNK 5a |
10mg | ¥64000 | 2024-03-01 | 購入 |
富士フイルム和光純薬株式會社(wako) | W01TOC2827 | TCS JNK 5a |
50mg | ¥270000 | 2024-03-01 | 購入 |
プロパティ
融點(diǎn) :88-90oC
沸點(diǎn) :486.8±45.0 °C(Predicted)
比重(密度) :1.32±0.1 g/cm3 (20 ºC 760 Torr)
貯蔵溫度 :Keep in dark place,Sealed in dry,Room Temperature
溶解性 :Soluble in DMSO (up to 13 mg/ml with warming) or in Ethanol (up to 4 mg/ml with warming)
外見 :Tan solid
酸解離定數(shù)(Pka) :11.95±0.20(Predicted)
色 :Off-white
安定性: :Stable for 2 years from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20°C for up to 3 months.
沸點(diǎn) :486.8±45.0 °C(Predicted)
比重(密度) :1.32±0.1 g/cm3 (20 ºC 760 Torr)
貯蔵溫度 :Keep in dark place,Sealed in dry,Room Temperature
溶解性 :Soluble in DMSO (up to 13 mg/ml with warming) or in Ethanol (up to 4 mg/ml with warming)
外見 :Tan solid
酸解離定數(shù)(Pka) :11.95±0.20(Predicted)
色 :Off-white
安定性: :Stable for 2 years from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20°C for up to 3 months.
安全情報(bào)
絵表示(GHS): | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
注意喚起語: | Warning | ||||||||||||||||||||||||||||||
危険有害性情報(bào): |
|
||||||||||||||||||||||||||||||
注意書き: |
|
説明
c-Jun N-terminal kinases (JNKs) are MAP kinase family members that become highly activated after cells are exposed to stress conditions and are poorly activated by exposure to growth factors or mitogens. They have been implicated in neurodegeneration, rheumatoid arthritis, inflammation, cancer, and diabetes. JNK1 and JNK2 are widely expressed throughout the body whereas JNK3 is predominantly distributed in the brain. JNK Inhibitor IX is a thienylnaphthamide compound that targets the ATP binding site of JNK2 and JNK3, disrupting activity with pIC50 values of 6.5 and 6.7, respectively. It demonstrates little activity against JNK1, p38α, and a panel of more than 30 other kinases (pIC50 < 5.0).関連商品価格
- ベネトクラクス
¥12500-26300 - 2,6-ジヒドロ-1,2-ジアザアセアントリレン-6-オン
¥7200-145000 - 3-[4-(ジメチルアミノ)ブタ-2-エンアミド]-N-(3-メチル-4-{[4-(ピリジン-3-イル)ピリミジン-2-イル]アミノ}フェニル)ベンズアミド
¥38700-96800
供給者とメーカー
ATK CHEMICAL COMPANY LIMITED
career henan chemical co
Hubei Jusheng Technology Co.,Ltd.
TargetMol Chemicals Inc.
Dideu Industries Group Limited
Zhejiang J&C Biological Technology Co.,Limited
InvivoChem
LEAP CHEM CO., LTD.
Coresyn Pharmatech Co., Ltd.
ShenZhen Trendseen Biological Technology Co.,Ltd.